Yichen Li

Dr. Yichen Li

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
YLYichen Li
Yichen Li
WWWenxia Wang
Wenxia Wang
YLYuxuan Liu
Yuxuan Liu
SLSenru Li
Senru Li
JWJingyu Wang
Jingyu Wang
LHLinlin Hou
Linlin Hou
Guanylate binding protein 5 (GBP5) is an emerging immune component that has been increasingly recognized for its involvement in autoimmune diseases, particularly inflammatory bowel disease (IBD). IBD is a complex disease involving inflammation of the gastrointestinal tract. Here, we explored the functional significance of GBP5 using Gbp5 knockout mice and wildtype mice exposed to dextran sulfate sodium (DSS) to generate chronic colitis model. We found that Gbp5 deficiency protected mice from DSS-induced chronic colitis. Transcriptome analysis of colon tissues showed reduced immune responses in Gbp5 knockout mice compared to those in corresponding wildtype mice. We further observed that after repeated DSS exposure, the gut microbiota was altered, both in wildtype mice and Gbp5 knockout mice; however, the gut microbiome health index was higher in the Gbp5 knockout mice. Notably, a probiotic murine commensal bacterium, Dubosiella, was predominantly enriched in these knockout mice. Our findings suggest that GBP5 plays an important role in promoting inflammation and dysbiosis in the intestine, the prevention of which might therefore be worth exploring in regards to IBD treatment.

22 December 2023 in Gastroenterology Report
Verified
Journal Article
Open access
PDF file
YLYichen Li
Yichen Li
JHJun Hu
Jun Hu
MZMin Zhi
Min Zhi
Wu et al. [ 1] recently published a study on potential prognostic and therapeutic values of immune cell infiltration (ICI) subtypes in colorectal cancer (CRC). In this study, they creatively designed a new approach combining the CIBERSORT and ESTIMATE methods to assess the differences in the intra-tumor immune infiltration landscape of CRC samples and its association with prognosis. They found that tumors with a high ICI score had a better prognosis, which was characterized by increased tumor mutational burden (TMB), increased expression of genes involved in immune checkpoints, chemokines, and the interleukin-17 (IL-17) signaling pathway. These results may help predict the prognosis of CRC patients receiving immune checkpoint therapy (ICT) and identify new potential immunotherapy targets for CRC.

1 July 2021 in Annals of Oncology
Verified
Journal Article
Closed access
HCH. Chen
H. Chen
YWYingzi Wu
Yingzi Wu
YCY. Chen
Y. Chen
EMEileen McGowan
Eileen McGowan
YLYichen Li
Yichen Li

26 August 2026 in Journal of Applied Toxicology
Verified
Journal Article
Closed access
YLYichen Li
Yichen Li
JGJiaqian Gong
Jiaqian Gong
RLRui Liu
Rui Liu
YZYuehang Zhang
Yuehang Zhang